1033 Nebulized/Swallowed vs Viscous/Swallowed Budesonide for Treatment of Eosinophilic Esophagitis: Results From a Randomized, Open-Label, Clinical Trial

Evan S. Dellon; Arif Sheikh; Olga Speck; Kimberly Woodward; Ann Whitlow; Jessica Hores; Marija Ivanovic; Allen Chau; John T. Woosley; Ryan D. Madanick; Roy C. Orlando; Nicholas J. Shaheen

doi:10.1016/S0016-5085(12)60676-3

Back

1033 Nebulized/Swallowed vs Viscous/Swallowed Budesonide for Treatment of Eosinophilic Esophagitis: Results From a Randomized, Open-Label, Clinical Trial

Journal article

Peer reviewed

1033 Nebulized/Swallowed vs Viscous/Swallowed Budesonide for Treatment of Eosinophilic Esophagitis: Results From a Randomized, Open-Label, Clinical Trial

Evan S. Dellon, Arif Sheikh, Olga Speck, Kimberly Woodward, Ann Whitlow, Jessica Hores, Marija Ivanovic, Allen Chau, John T. Woosley, Ryan D. Madanick, …

Gastroenterology (New York, N.Y. 1943), Vol.142(5), pp.S-180-S-180

05/2012

DOI: https://doi.org/10.1016/S0016-5085(12)60676-3

Metrics

1 Record Views

Details

Title: 1033 Nebulized/Swallowed vs Viscous/Swallowed Budesonide for Treatment of Eosinophilic Esophagitis: Results From a Randomized, Open-Label, Clinical Trial
Creators - without role: Evan S. Dellon
Arif Sheikh
Olga Speck
Kimberly Woodward
Ann Whitlow
Jessica Hores
Marija Ivanovic
Allen Chau
John T. Woosley
Ryan D. Madanick
Roy C. Orlando
Nicholas J. Shaheen
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.142(5), pp.S-180-S-180
Identifiers: 9920827708331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article